Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
63
天
Elevated DSG3 Expression Is Correlated With Lung Cancer Progression and Poor Prognosis
作者
Jian Yang; Hongyuan Chen; Jiang Hong; Xiaowei Wang展开收起
作者单位
1. Department of Nuclear Medicine Changhai Hospital Shanghai China; 2. Department of Pathology Changhai Hospital Shanghai China; 3. Department of Thoracic Surgery Changhai Hospital Shanghai China展开收起
86
天
Unveiling MLLT3: A Key Transcription Factor in ESCC Prognosis and Immune Infiltration
作者
Shuolei Li; Yashu Zhang; Yongtao Bai展开收起
作者单位
1. Department of Pharmacy Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou Henan China; 2. Phase I Clinical Research Center Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou Henan China; 3. Henan Engineering Research Center for Tumor Precision Medicine and Comprehensive Evaluation, Henan Cancer Hospital Zhengzhou Henan China; 4. Henan Provincial Key Laboratory of Anticancer Drug Research, Henan Cancer Hospital Zhengzhou Henan China; 5. Department of Spleen Stomach and Liver Diseases, Zhengzhou Hospital of Traditional Chinese Medicine Zhengzhou Henan China展开收起
242
天
SF3A3 Promotes Hepatocellular Carcinoma Progression and Regulates Jagged 2–Notch 1 Signaling
作者
Jing Yang; Luyang Liu; Yan Zhang; Guangwen Zhou展开收起
作者单位
1. Department of General Surgery Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai Shanghai China; 2. Department of General Visceral & Transplantation Surgery, Heidelberg University Hospital Heidelberg Baden‐Württemberg Germany; 3. Department of Oncology Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai Shanghai China展开收起
232
天
Elevated UBE2L6 Expression Predicts Poor Prognosis and Is Associated With Fatty Acid Metabolic Remodeling in Esophageal Cancer
作者
Miss Jiaxin Yao; Miss Lu Wen; Miss Jinyue Ma; Miss Rendan Zhang; Miss Xianhua Hu; Miss Chunyan Zhao; Mr Bo Mu展开收起
作者单位
1. School of Basic Medicine and Forensic Medicine, Sichuan North Medical College Nanchong City China; 2. Department of Graduate Students Sichuan North Medical College Nanchong City China; 3. Key Laboratory of Medical Imaging of Sichuan Province, Sichuan North Medical College Nanchong City China展开收起
11
天
Fusion Detection in Microsecretory Adenocarcinoma and Mucoepidermoid Carcinoma Using Chromogenic RNA In Situ Hybridization: A Promising Alternative to DNA‐Based Fluorescence In‐Situ Hybridization
作者
Doreen N. Palsgrove; Calvin Hosler; Lisa M. Rooper; Dequan Weston; Andrew Day; Justin A. Bishop; Richard C. Wang展开收起
作者单位
1. Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA; 2. Medical School Louisiana State University Health Science Center New Orleans Louisiana USA; 3. Department of Pathology The Johns Hopkins Hospital Baltimore Maryland USA; 4. Department of Otolaryngology‐Head and Neck Surgery University of Texas Southwestern Medical Center Dallas Texas USA; 5. Department of Dermatology, University of Colorado Anschutz Medical Campus (CU AMC) School of Medicine Aurora Colorado USA; 6. University of Colorado Cancer Center Aurora Colorado USA展开收起
57
天
USP4‐Mediated Deubiquitination of PTBP1 Promotes Glioma Progression and Radioresistance by Enhancing PHB2‐Dependent Mitophagy
作者
Tao Liu; Qingyao Zhu; Linwei Li; Xiaoyan Li; Wei Wang展开收起
作者单位
1. Department of Oncology, Henan Provincial People's Hospital Zhengzhou University People's Hospital, Henan University People's Hospital Zhengzhou China展开收起
FAQ
MOLECULAR CARCINOGENESIS审稿要多久?
截至2026-11-17,CrushSCI 收录了 MOLECULAR CARCINOGENESIS 的 30 篇完整审稿记录。最快一篇从收稿到录用用了 11 天(Fusion Detection in Microsecretory Adenocarcinoma and Mucoepidermoid Carcinoma Using Chromogenic RNA In Situ Hybridization: A Promising Alternative to DNA‐Based Fluorescence In‐Situ Hybridization,2026-08-24 收稿,2026-09-04 录用),最慢一篇用了 350 天;平均 134.1 天,中位数 124 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
